Pharmacotherapy

Papers
(The TQCC of Pharmacotherapy is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
Update and narrative review of avian influenza (H5N1) infection in adult patients98
Characterization of lamotrigine disposition changes during and after pregnancy in women with epilepsy94
67
Changes in serum potassium in people with type 2 diabetes taking sodium‐glucose co‐transporter‐2 inhibitors54
Warfarin dosage in a postpartum woman while breastfeeding: A case report52
Association of bleeding with serotonergic antidepressants in patients receiving left ventricular assist device support42
Acid‐suppressive drugs: A systematic review and network meta‐analysis of their nocturnal acid‐inhibitory effect39
Hydroxyurea treatment for sickle cell anemia during pregnancy and lactation: Current evidence and knowledge gaps39
Comparison of risk‐scoring systems for heparin‐induced thrombocytopenia in cardiac surgery patients38
Safety and efficacy of cefiderocol for off‐label treatment indications: A systematic review35
Assessment and management of iatrogenic withdrawal syndrome and delirium in pediatric intensive care units across Europe: An ESPNIC survey35
Empiric dosing strategies to predict lamotrigine concentrations during pregnancy35
Comparative safety and efficacy of bisphosphonates, denosumab, and parathyroid hormone analogs for osteoporosis following lung transplantation30
Impact of concurrent gabapentin or pregabalin with high‐dose melphalan in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplant29
29
Statin‐associated muscle symptoms—A review: Individualizing the approach to optimize care29
Reduced risk of NSAID‐Induced adverse events with concomitant use of misoprostol (MICRO study)29
Optimal starting dosing regimen of intravenous oxytocin for labor induction based on the population kinetic‐pharmacodynamic model of uterine contraction frequency28
Determination of vancomycin exposure target and individualized dosing recommendations for critically ill patients undergoing continuous renal replacement therapy27
Biomarkers in the intensive care setting: A focus on using procalcitonin and C‐reactive protein to optimize antimicrobial duration of therapy27
Patient safety outcomes for continuous infusion vancomycin as outpatient parenteral antimicrobial therapy27
Response to comment on “Dosing implications for liposomal amphotericin B in pregnancy”26
Comment on “Evaluation of the safety and tolerability of intravenous undiluted levetiracetam at a pediatric institution”25
Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment‐experienced and/or have multidrug‐resistant HIV‐1: Endorse24
Evaluation of the safety and tolerability of intravenous undiluted levetiracetam at a pediatric institution23
Reversal of apixaban and rivaroxaban with andexanet alfa prior to invasive or surgical procedures21
Oral fluoroquinolones and risk of aortic aneurysm or dissection: A nationwide population‐based propensity score‐matched cohort study21
Role of maternal COVID‐19 vaccination in providing immunological protection to the newborn21
20
Issue Information20
Role of the gut microbiome in cardiovascular drug response: The potential for clinical application19
Management of diffuse alveolar hemorrhage in the hematopoietic stem cell transplantation population: A systematic review19
18
Pharmacokinetic and pharmacodynamic evaluation of sulbactam‐durlobactam in a critically ill patient on continuous venovenous hemofiltration infected with carbapenem‐resistant Acinetobacter baumanni17
Effect of P2Y12 Inhibitors on Major Adverse Cardiovascular Events After Coronary Artery Bypass Graft Surgery: A Population‐Based Cohort Study17
Approaches to Precision‐based Anticoagulation management in the critically Ill17
Early combination therapy with immunoglobulin and steroids is associated with shorter ICU length of stay in Multisystem Inflammatory Syndrome in Children (MIS‐C) associated with 17
Effect of creatine monohydrate on motor function in children with facioscapulohumeral muscular dystrophy: A multicenter, randomized, double‐blind placebo‐controlled crossover trial17
16
Cefazolin in the treatment of central nervous system infections: A narrative review and recommendation16
Issue Information16
Pharmacotherapy research landscape and knowledge gaps of opioids in maternal and pediatric populations16
16
Adverse Effects of Antidepressant Medications and their Management in Children and Adolescents16
Issue Information15
Use of proton pump inhibitors and risk of severe COVID‐19: A case–control study in United States Medicare beneficiaries15
Impact of dexmedetomidine in conjunction with a weaning protocol on post‐surgical opioid use in a neonatal intensive care unit15
14
Proton pump inhibitor concomitant use to prevent oxaliplatin‐induced peripheral neuropathy: Clinical retrospective cohort study14
Issue Information14
Comment on “Intravenous ketamine successfully treats treatment‐resistant catatonia in schizophrenia: A case report”14
Current therapies and challenges for the treatment of Staphylococcus aureus biofilm‐related infections14
Issue Information13
Hydrocortisone versus vasopressin for the management of adult patients with septic shock refractory to norepinephrine: A multicenter retrospective study13
Issue Information13
Pain management considerations in patients living with both pain syndromes and cardiovascular diseases and disorders13
Cardiovascular and kidney outcomes of spironolactone or eplerenone in combination with ACEI/ARBs in patients with diabetic kidney disease13
Open‐source maximum a posteriori‐bayesian dosing AdDS to current therapeutic drug monitoring: Adapting to the era of individualized therapy13
Impact of concomitant fluconazole on direct oral anticoagulant bleeding risk12
12
Reply to Comment on: Tacrolimus in the treatment of childhood nephrotic syndrome: Machine learning detects novel biomarkers and predicts efficacy12
Risks of serious adverse events and kidney injury in patients treated with ibandronate: A systematic review and meta‐analysis12
A dose‐escalation clinical trial of intranasal ketamine for uncontrolled cancer‐related pain12
Efficacy and safety of factor Xa inhibitors in low body weight patients12
Fluoroquinolones and the risk of aortic aneurysm or dissection: A population‐based propensity score‐matched German cohort study12
Scoping review of rational polytherapy in patients with drug‐resistant epilepsy11
The role of inflammation in the pathogenesis and treatment of arrhythmias11
Critique of “Angiotensin‐converting enzyme inhibitors reduce community‐acquired pneumonia hospitalization and mortality”11
Effects of statin therapy and treatment duration on cardiovascular disease risk in patients with nephrotic syndrome: A nested case–control study11
Performance of different body weights in the Cockcroft‐Gault equation in critically ill patients with and without augmented renal clearance: A multicenter cohort11
Caring for two in the ICU: Pharmacologic management of pregnancy‐related complications11
A pharmacogenetic precision medicine approach to analgesia and sedation optimization in critically ill adults10
Comment on “The power and pitfalls of underpowered studies”10
External evaluation of neonatal vancomycin population pharmacokinetic models: Moving from first‐order equations to Bayesian‐guided therapeutic monitoring10
Issue Information10
Buprenorphine initiation strategies for opioid use disorder and pain management: A systematic review10
Current clinical pharmacology issues in pregnancy and pediatrics10
Issue Information10
Standards of practice to advance the quality of health care10
Impact of medication intensification on 30‐day hospital readmissions in a geriatric trauma population: A multicenter cohort study10
Association between household opioid prescriptions and risk for overdose among family members not prescribed opioids9
Impact of pre‐lung transplant statin use on the development of primary graft dysfunction9
Oral stepdown in Gram‐positive bloodstream infections: A step in the right direction9
Evaluation of anti‐factor Xa concentrations using a body mass index‐based enoxaparin dosing protocol for venous thromboembolism prophylaxis in trauma patients9
Myocardial infarction associated with erenumab: A case report9
Effect of proton pump inhibitors versus histamine‐2 receptor antagonists on acute kidney injury in septic patients at high risk for developing stress ulcers9
Serum potassium response to single‐dose sodium zirconium cyclosilicate for the treatment of asymptomatic hyperkalemia in hospitalized patients9
Update on the clinical applications of SGLTis: Insight to benefits beyond hypoglycemic and cardiorenal protection9
Correction to “Comparative adherence trajectories of oral disease‐modifying agents in multiple sclerosis”9
Response to comment on “Intravenous ketamine successfully treats treatment‐resistant catatonia in schizophrenia: A case report”9
Cross‐titration from risperidone to clozapine utilizing clozapine serum concentrations: A case report9
Comment on “Tacrolimus in the treatment of childhood nephrotic syndrome: Machine learning detects novel biomarkers and predicts efficacy”8
Metformin use is associated with reduced acute kidney injury following coronary artery bypass grafting in patients with type 2 diabetes: An inverse probability of treatment weighting analysis8
Aztreonam–avibactam: The dynamic duo against multidrug‐resistant gram‐negative pathogens8
Tacrolimus in the treatment of childhood nephrotic syndrome: Machine learning detects novel biomarkers and predicts efficacy8
Pharmacokinetic parameters over time during sepsis and the association of target attainment and outcomes in critically ill children and young adults receiving ceftriaxone8
Managing attention‐deficit/hyperactivity disorder in a breastfeeding mother: A case report8
Temporal shifts in safety and efficacy profile of mycophenolate mofetil 2 g versus 3 g daily early after heart transplantation8
Precision‐based approaches to delirium in critical illness: A narrative review8
Vancomycin: An analysis and evaluation of eight population pharmacokinetic models for clinical application in general adult population8
Emerging therapies for eosinophilic esophagitis8
The efficacy and safety of sodium‐glucose cotransporter‐2 inhibitors in solid organ transplant recipients: A scoping review8
Issue Information8
Response to comment on “International consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society7
Association of Pneumonia, Fracture, Metabolic, and Renal Events With Long‐Term Proton Pump Inhibitor Use in Patients With Chronic Kidney Disease7
Evaluation of hyponatremia among older adults exposed to selective serotonin reuptake inhibitors and thiazide diuretics7
The effect of antipsychotic treatment on hormonal, inflammatory, and metabolic biomarkers in healthy volunteers: A systematic review and meta‐analysis7
Clinical outcomes associated with anti‐Xa‐monitored enoxaparin for venous thromboembolism prophylaxis7
Cardiovascular adverse events in patients with hepatocellular carcinoma receiving vascular endothelial growth factor inhibitors7
“Comment on ‘international consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimi7
Genome‐wide associations with metabolic syndrome among UK Biobank participants reporting use of second‐generation antipsychotics7
Use of naldemedine is associated with reduced incidence of hyperactive delirium in cancer patients with opioid‐induced constipation: A nationwide retrospective cohort study in Japan7
7
Pharmacokinetics/pharmacodynamics analysis and establishment of optimal dosing regimens using unbound cefmetazole concentration for patients infected with Extended‐Spectrum β‐lactamase prod7
Assessment of a modified MINDS‐based protocol for management of alcohol withdrawal syndrome on an inpatient medical service7
Population pharmacokinetics of linezolid and its major metabolites PNU‐142300 and PNU‐142586 in adult patients7
TheMPRINTHub Data, Model, Knowledge and Research Coordination Center: Bridging the gap in maternal–pediatric therapeutics research through data integration and pharmacometrics7
Steno‐sphere: Navigating the enigmatic world of emerging multidrug‐resistantStenotrophomonas maltophilia7
7
Beneficial and harmful outcomes of tocilizumab in severe COVID‐19: A systematic review and meta‐analysis7
Comparison of Bayesian‐derived and first‐order analytic equations for calculation of vancomycin area under the curve6
Efficacy of adjuvant use of midodrine in patients with septic shock: An open label randomized controlled trial6
Prevalence of prescription medication use that can exacerbate heart failure among US adults with heart failure6
Retrospective cohort study of oral switch versus intravenous antibiotics for carbapenem‐resistant enterobacterales and Pseudomonas aeruginosa infections on hospital discharge6
Biological Therapy and Small Molecules for Adults With Crohn's Disease: Systematic Review and Network Meta‐Analysis6
Issue Information6
Response to Comment on “Proton Pump Inhibitor Concomitant Use to Prevent Oxaliplatin‐Induced Peripheral Neuropathy: Clinical Retrospective Cohort Study”6
Intraperitoneal Granisetron for Post‐Laparoscopic Cholecystectomy Pain Management: A Double‐Blinded, Randomized Controlled Trial6
Transfer of antibiotics and their metabolites in human milk: Implications for infant health and microbiota6
Effect of cilostazol on preventing paclitaxel‐induced neuropathy in patients with breast cancer: A randomized controlled trial6
Expert consensus recommendations for innovative antiretroviral drugs6
Issue Information6
6
Correction of posaconazole concentrations for hypoalbuminemia6
Comparison of catheter‐related bloodstream infection rates in pediatric patients receiving parenteral nutrition with soybean oil‐based intravenous fat emulsion versus a mixed oil fat emulsion6
6
0.72224593162537